大葡萄
Lv11
100 积分
2022-05-17 加入
-
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
5小时前
待确认
-
Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 Trial
28天前
已完结
-
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
2个月前
已完结
-
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
3个月前
已完结
-
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials
3个月前
已完结
-
Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
3个月前
已完结
-
Expression and purification of exendin-4, a GLP-1 receptor agonist, in Escherichia coli
3个月前
已完结
-
Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas
3个月前
已完结
-
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
3个月前
已完结
-
Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications
3个月前
已完结